{
    "article_id": "PMC7640586",
    "article_text_type": "fulltext",
    "article_filtered_sentences": [
        "The primary outcome was progression-free survival (PFS).",
        "Methods - Outcomes\nThe primary endpoint was PFS, defined as the time from randomisation to investigator-assessed disease progression according to Response Evaluation Criteria in Solid Tumours (RECIST), V.1.1, \n       15 or death from any cause."
    ],
    "registry_id": "NCT01640405",
    "registry_primary_outcomes": [
        "Progression free survival (PFS) , 5 years"
    ],
    "labels": {
        "POS_identif_possible": "Yes",
        "PO_switch": "No",
        "PO_not_reported_registry": "No",
        "PO_not_reported_publication": "No",
        "POS_timeframe_metric": "No",
        "Description": ""
    },
    "article_bio_outcomes": [
        {
            "sentence_nb": 1,
            "tokens": [
                "Methods",
                "-",
                "Outcomes",
                "The",
                "primary",
                "endpoint",
                "was",
                "PFS",
                ",",
                "defined",
                "as",
                "the",
                "time",
                "from",
                "randomisation",
                "to",
                "investigator-assessed",
                "disease",
                "progression",
                "according",
                "to",
                "Response",
                "Evaluation",
                "Criteria",
                "in",
                "Solid",
                "Tumours",
                "(",
                "RECIST",
                ")",
                ",",
                "V",
                ".1.1",
                ",",
                "15",
                "or",
                "death",
                "from",
                "any",
                "cause",
                "."
            ],
            "labels": [
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "O"
            ]
        },
        {
            "sentence_nb": 0,
            "tokens": [
                "The",
                "primary",
                "outcome",
                "was",
                "progression-free",
                "survival",
                "(",
                "PFS",
                ")",
                "."
            ],
            "labels": [
                "O",
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "O"
            ]
        }
    ],
    "article_outcomes_text": [
        "PFS , defined as the time from randomisation to investigator-assessed disease progression according to Response Evaluation Criteria in Solid Tumours ( RECIST ) , V .1.1 , 15 or death from any cause",
        "progression-free survival ( PFS )"
    ],
    "article2article_connections": [
        [
            0,
            1,
            true
        ]
    ],
    "filtered_article_outcomes": [
        "PFS , defined as the time from randomisation to investigator-assessed disease progression according to Response Evaluation Criteria in Solid Tumours ( RECIST ) , V .1.1 , 15 or death from any cause"
    ],
    "article2registry_connections": [
        {
            "article_index": 0,
            "registry_index": 0,
            "similar": true
        }
    ]
}